
|Articles|July 9, 2019
Symbio Signs Five-Year Agreement for OmniComm’s TrialMaster
Advertisement
Symbio LLC has announced the signing of a five-year contract with OmniComm Systems, Inc., to use their TrialMaster version 5 to develop and manage clinical study databases.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement